The US FDA's approval of Teva Pharmaceutical Industries Ltd.'s generic version of EpiPen (epinephrine) auto-injector is a boon for the agency as well as the company. Teva overcame problems with its initial ANDA and FDA achieved part of its goal of helping to bring complex generics to market.
"Today's approval of the first generic version of the most-widely prescribed epinephrine auto-injector in the U.S. is part of our...






